BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36931398)

  • 1. Relationship between iron deficiency and expression of genes involved in iron metabolism in human myocardium and skeletal muscle.
    Cabrera C; Frisk C; Löfström U; Lyngå P; Linde C; Hage C; Persson H; Eriksson MJ; Wallén H; Persson B; Ekström M
    Int J Cardiol; 2023 May; 379():82-88. PubMed ID: 36931398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence and clinical associations of iron deficiency in patients with decompensated heart failure, depending on the diagnostic criteria used for iron deficiency].
    Kobalava ZD; Lapshin AA; Tolkacheva VV; Galochkin SA
    Ter Arkh; 2022 Aug; 94(7):844-849. PubMed ID: 36286941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of Iron Metabolism and Outcomes in Patients with Heart Failure: A Systematic Review.
    Dhaliwal S; Kalogeropoulos AP
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial.
    Lewis GD; Malhotra R; Hernandez AF; McNulty SE; Smith A; Felker GM; Tang WHW; LaRue SJ; Redfield MM; Semigran MJ; Givertz MM; Van Buren P; Whellan D; Anstrom KJ; Shah MR; Desvigne-Nickens P; Butler J; Braunwald E;
    JAMA; 2017 May; 317(19):1958-1966. PubMed ID: 28510680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron deficiency is an independent risk factor of increased myocardial energy expenditure in chronic heart failure patients.
    Lin F; Huang Y; An D; Zhan Q; Wang P; Lai W; Zeng Q; Dong S; Ren H; Xu D
    Ann Palliat Med; 2021 Dec; 10(12):12061-12071. PubMed ID: 35016401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Soluble Transferrin Receptor and Clinical Outcomes in Patients With Heart Failure According to Ejection Fraction Phenotype: The New Zealand PEOPLE Study.
    Fitzsimons S; Poppe KK; Choi Y; Devlin G; Lund M; Lam CSP; Troughton R; Richards AM; Doughty RN
    J Card Fail; 2022 Aug; 28(8):1255-1263. PubMed ID: 35051624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron deficiency and short-term adverse events in patients with decompensated heart failure.
    Palau P; Llàcer P; Domínguez E; Tormo JP; Zakarne R; Mollar A; Martínez A; Miñana G; Santas E; Almenar L; Fácila L; De La Espriella R; Núñez E; Manzano L; Bayés-Genís A; Núñez J
    Clin Res Cardiol; 2021 Aug; 110(8):1292-1298. PubMed ID: 33721056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Deficiency in Heart Failure with Reduced Ejection Fraction: Pathophysiology, Diagnosis and Treatment.
    Pereira GAR; Beck-da-Silva L
    Arq Bras Cardiol; 2022 Mar; 118(3):646-654. PubMed ID: 35319614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria for Iron Deficiency in Patients With Heart Failure.
    Masini G; Graham FJ; Pellicori P; Cleland JGF; Cuthbert JJ; Kazmi S; Inciardi RM; Clark AL
    J Am Coll Cardiol; 2022 Feb; 79(4):341-351. PubMed ID: 35086656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial iron homeostasis in advanced chronic heart failure patients.
    Leszek P; Sochanowicz B; Szperl M; Kolsut P; Brzóska K; Piotrowski W; Rywik TM; Danko B; Polkowska-Motrenko H; Różański JM; Kruszewski M
    Int J Cardiol; 2012 Aug; 159(1):47-52. PubMed ID: 21899903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate Noninvasive Assessment of Myocardial Iron Load in Advanced Heart Failure Patients.
    Leszek P; Sochanowicz B; Brzóska K; Kraj L; Kuśmierczyk M; Śmigielski W; Rywik TM; Sobieszczańska-Małek M; Rozentryt P; Kruszewski M
    Dis Markers; 2020; 2020():8885189. PubMed ID: 33224316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply to Letter to the Editor for the "Relationship between iron deficiency and expression of genes involved in iron metabolism in human myocardium and skeletal muscle".
    Int J Cardiol; 2023 Aug; 385():43. PubMed ID: 37150214
    [No Abstract]   [Full Text] [Related]  

  • 14. Iron deficiency is related to lower muscle mass in community-dwelling individuals and impairs myoblast proliferation.
    Vinke JSJ; Gorter AR; Eisenga MF; Dam WA; van der Meer P; van den Born J; Bakker SJL; Hoes MF; de Borst MH
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1865-1879. PubMed ID: 37386912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype.
    Fitzsimons S; Yeo TJ; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Poppe K; Lund M; Devlin G; Troughton R; Lam CSP; Richards AM; Doughty RN
    ESC Heart Fail; 2021 Dec; 8(6):4572-4583. PubMed ID: 34592056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute heart failure and iron deficiency: a prospective, multicentre, observational study.
    van Dalen DH; Kragten JA; Emans ME; van Ofwegen-Hanekamp CEE; Klaarwater CCR; Spanjers MHA; Hendrick R; van Deursen CTBM; Brunner-La Rocca HP
    ESC Heart Fail; 2022 Feb; 9(1):398-407. PubMed ID: 34862747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between serum iron level and physical function in heart failure patients is lost by presence of diabetes.
    Ohori K; Yano T; Katano S; Nagaoka R; Numazawa R; Yamano K; Fujisawa Y; Kouzu H; Nagano N; Fujito T; Nishikawa R; Ohwada W; Sato T; Furuhashi M
    ESC Heart Fail; 2024 Feb; 11(1):513-523. PubMed ID: 38088258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter to the editor for the "relationship between iron deficiency and expression of genes involved in iron metabolism in human myocardium and skeletal muscle".
    Cirovic A; Cirovic A
    Int J Cardiol; 2023 Aug; 384():75. PubMed ID: 37087055
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction.
    López-Vilella R; Lozano-Edo S; Arenas Martín P; Jover-Pastor P; Ezzitouny M; Sorolla Romero J; Calvo Asensio M; Martínez-Solé J; Guerrero Cervera B; Sánchez Martínez JC; Donoso Trenado V; Sánchez-Lázaro I; Martinez Dolz L; Almenar Bonet L
    ESC Heart Fail; 2022 Feb; 9(1):133-145. PubMed ID: 34964300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability of new proposed criteria for iron deficiency in Japanese patients with heart failure.
    Tada A; Nagai T; Koya T; Nakao M; Ishizaka S; Mizuguchi Y; Aoyagi H; Imagawa S; Tokuda Y; Takahashi M; Kato Y; Machida M; Matsutani K; Saito T; Anzai T;
    ESC Heart Fail; 2023 Apr; 10(2):985-994. PubMed ID: 36495060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.